Turk J Med Sci. 2019 Feb 11;49(1):123-128. doi: 10.3906/sag-1805-21.
BACKGROUND/AIM: We investigated the association of three IL-10 promoter single-nucleotide polymorphisms and altered IL-10 plasma levels with the risk of head and neck cancer (HNC).
Study subjects comprised 194 HNC patients [137 nasopharyngeal cancer (NPC) and 57 laryngeal cancer (LC)], and 263 healthy controls. Genotyping of rs1800896 (-1082A>G), rs1800871 (-819C>T), and rs1800872 (-592A>C) IL-10 variants was performed by real-time PCR; IL-10 levels were measured by enzyme amplified immuno sensitivity assay (EAISA).
Study subjects comprised 194 HNC patients [137 nasopharyngeal cancer (NPC) and 57 laryngeal cancer (LC)], and 263 healthy controls. Genotyping of rs1800896 (-1082A>G), rs1800871 (-819C>T), and rs1800872 (-592A>C) IL-10 variants was performed by real-time PCR; IL-10 levels were measured by enzyme amplified immuno sensitivity assay (EAISA).
Our results demonstrate that IL-10-1082, IL-10-819, and IL-10-592 variants, and haplotypes GC and GT constitute biomarkers for early detection of HNC, especially NPC subtype. IL-10 -819T/C and TA haplotype may be used as biomarkers for early detection of LC.
背景/目的:我们研究了三个白细胞介素 10(IL-10)启动子单核苷酸多态性与白细胞介素 10 血浆水平改变与头颈部癌症(HNC)风险之间的关联。
研究对象包括 194 例 HNC 患者[137 例鼻咽癌(NPC)和 57 例喉癌(LC)]和 263 例健康对照。采用实时 PCR 法对 IL-10 变异 rs1800896(-1082A>G)、rs1800871(-819C>T)和 rs1800872(-592A>C)进行基因分型;采用酶放大免疫敏感性测定法(EAISA)检测 IL-10 水平。
研究对象包括 194 例 HNC 患者[137 例鼻咽癌(NPC)和 57 例喉癌(LC)]和 263 例健康对照。采用实时 PCR 法对 IL-10 变异 rs1800896(-1082A>G)、rs1800871(-819C>T)和 rs1800872(-592A>C)进行基因分型;采用酶放大免疫敏感性测定法(EAISA)检测 IL-10 水平。
我们的研究结果表明,IL-10-1082、IL-10-819 和 IL-10-592 变异体以及 GC 和 GT 单倍型可作为 HNC,尤其是 NPC 亚型的早期检测标志物。IL-10-819T/C 和 TA 单倍型可作为 LC 早期检测的标志物。